$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

$bnet Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000107997323000168 Filed on February 08, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2021 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$838.0K	$607.5K	$618.0K
YoY Change	110.69%	-1.69%	111.86%
% of Gross Profit
Research & Development	$24.24K	$15.15K	$54.40K
YoY Change	-17.57%	-72.15%	-64.99%
% of Gross Profit
Depreciation & Amortization	$461.00	$394.00	$330.00
YoY Change	84.4%	19.39%	59.42%
% of Gross Profit
Operating Expenses	$883.7K	$646.1K	$672.7K
YoY Change	106.76%	-3.96%	50.4%
Operating Profit	-$883.7K	-$646.1K	-$672.7K
YoY Change	106.76%	-3.96%	50.4%
Interest Expense	$25.83K	$85.29K	-$117.1K
YoY Change	-151.64%	-172.83%	-138.63%
% of Operating Profit
Other Income/Expense, Net	$25.83K	-$83.91K	$10.12M
YoY Change	-96.97%	-100.83%	-3437.19%
Pretax Income	-$857.9K	-$730.0K	$9.445M
YoY Change	-301.83%	-107.73%	-1358.54%
Income Tax
% Of Pretax Income
Net Earnings	-$857.9K	-$730.0K	$9.445M
YoY Change	-301.57%	-107.73%	-1358.61%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.02	-$0.02
Diluted Earnings Per Share	-$0.02	-$0.02	$229.9K
COMMON SHARES
Basic Shares Outstanding	43.63M shares	43.63M shares
Diluted Shares Outstanding	45.46M shares	43.62M shares	41.09M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.613M	$1.101M	$4.948M
YoY Change	-55.22%	-77.74%	1270.03%
Cash & Equivalents	$1.613M	$1.101M	$4.948M
Short-Term Investments
Other Short-Term Assets	$119.1K	$78.49K	$47.72K
YoY Change	132.3%	64.48%	791.96%
Inventory
Prepaid Expenses	$113.1K	$77.49K
Receivables
Other Receivables
Total Short-Term Assets	$1.732M	$1.180M	$4.996M
YoY Change	-61.98%	-76.38%	1263.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.788M	$3.836M	$318.7K
YoY Change	190.53%	1103.56%	33309.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$5.895M	$3.956M	$318.7K
YoY Change	195.9%	1141.22%	33309.85%
TOTAL ASSETS
Total Short-Term Assets	$1.732M	$1.180M	$4.996M
Total Long-Term Assets	$5.895M	$3.956M	$318.7K
Total Assets	$7.627M	$5.136M	$5.315M
YoY Change	16.48%	-3.36%	1346.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$800.9K	$523.3K	$212.3K
YoY Change	-34.24%	146.52%	-64.62%
Accrued Expenses			$12.44K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$1.585M	$1.237M	$990.4K
YoY Change	-9.08%	24.94%	-91.31%
LONG-TERM LIABILITIES
Long-Term Debt	$1.736M	$5.300M	$5.076M
YoY Change	-66.12%	4.42%	7.76%
Other Long-Term Liabilities	$120.0K	$135.4K	$122.6K
YoY Change	-4.57%	10.46%
Total Long-Term Liabilities	$1.855M	$5.435M	$5.198M
YoY Change	-64.65%	4.56%	10.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.585M	$1.237M	$990.4K
Total Long-Term Liabilities	$1.855M	$5.435M	$5.198M
Total Liabilities	$3.441M	$6.673M	$6.227M
YoY Change	-51.06%	7.17%	-61.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$126.6M	-$125.7M
YoY Change
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.149M	-$1.574M	-$912.0K
YoY Change
Total Liabilities & Shareholders Equity	$7.627M	$5.136M	$5.315M
YoY Change	16.48%	-3.36%	1346.23%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2021 Q4
OPERATING ACTIVITIES
Net Income	-$857.9K	-$730.0K	$9.445M
YoY Change	-301.57%	-107.73%	-1358.61%
Depreciation, Depletion And Amortization	$461.00	$394.00	$330.00
YoY Change	84.4%	19.39%	59.42%
Cash From Operating Activities	-$559.3K	-$606.0K	-$503.0K
YoY Change	106.5%	20.48%	78.73%
INVESTING ACTIVITIES
Capital Expenditures	$1.664M	$416.8K	-$84.64K
YoY Change	-254.76%	-592.44%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.664M	-$416.8K	-$84.64K
YoY Change	54.76%	392.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.735M	226.2K	1.574M
YoY Change		-85.62%	413.4%
NET CHANGE
Cash From Operating Activities	-559.3K	-606.0K	-503.0K
Cash From Investing Activities	-1.664M	-416.8K	-84.64K
Cash From Financing Activities	2.735M	226.2K	1.574M
Net Change In Cash	511.5K	-796.5K	986.0K
YoY Change	-138.0%	-180.79%	3831.22%
FREE CASH FLOW
Cash From Operating Activities	-$559.3K	-$606.0K	-$503.0K
Capital Expenditures	$1.664M	$416.8K	-$84.64K
Free Cash Flow	-$2.223M	-$1.023M	-$418.3K
YoY Change	-376.39%	144.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000875729
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2022Q4	bnet	Gain On Legal Dissolution Of Subsidiary GainOnLegalDissolutionOfSubsidiary		usd
	bnet	Gain On Legal Dissolution Of Subsidiary GainOnLegalDissolutionOfSubsidiary		usd
CY2022Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	bnet	Gain On Legal Dissolutions Of Subsidiary GainOnLegalDissolutionsOfSubsidiary		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits		usd
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants		usd
	bnet	Redemption Of Preferred Series B Shares And Interest RedemptionOfPreferredSeriesBSharesAndInterest		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	bnet	Conversion Of Debt And Liabilities Into Notes Payable ConversionOfDebtAndLiabilitiesIntoNotesPayable		usd
	bnet	Capitalized Interest In Property And Equipment CapitalizedInterestInPropertyAndEquipment		usd
	bnet	Shares Issued For Warrant Exercise Commissions SharesIssuedForWarrantExerciseCommissions		usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross		usd
CY2022Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross		usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross		usd
CY2022Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-19333
	dei	Entity Registrant Name EntityRegistrantName	Bion Environmental Technologies, Inc
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1176672
	dei	Entity Address Address Line1 EntityAddressAddressLine1	9 East Park Court
	dei	Entity Address City Or Town EntityAddressCityOrTown	Old Bethpage
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11804
	dei	City Area Code CityAreaCode	516
	dei	Local Phone Number LocalPhoneNumber	586-5643
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	BNET
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43625575	shares
CY2022Q4	us-gaap	Cash Cash	1101450	usd
CY2022Q2	us-gaap	Cash Cash	3160442	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	77488	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	157550	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1000	usd
CY2022Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1179938	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	3318992	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	120058	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	145787	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3836097	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2895558	usd
CY2022Q4	us-gaap	Assets Assets	5136093	usd
CY2022Q2	us-gaap	Assets Assets	6360337	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	523277	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1360644	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	714222	usd
CY2022Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	594798	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1237499	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1955442	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	135443	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	128864	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	5300025	usd
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	5170610	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6672967	usd
CY2022Q2	us-gaap	Liabilities Liabilities	7254916	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44529884	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43758820	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43825575	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43054511	shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	124627172	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	123620046	usd
CY2022Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2022Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-125696969	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-124047548	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1574447	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-932152	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1536874	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-894579	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5136093	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6360337	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	630542	usd
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	617963	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1497036	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1109096	usd
CY2022Q4	us-gaap	Depreciation Depreciation	394	usd
CY2021Q4	us-gaap	Depreciation Depreciation	332	usd
	us-gaap	Depreciation Depreciation	724	usd
	us-gaap	Depreciation Depreciation	580	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15148	usd
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	54404	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43591	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	116213	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	646084	usd
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	672699	usd
	us-gaap	Operating Expenses OperatingExpenses	1541351	usd
	us-gaap	Operating Expenses OperatingExpenses	1225889	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-646084	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-672699	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1541351	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1225889	usd
CY2022Q4	us-gaap	Interest Income Operating InterestIncomeOperating	1375	usd
CY2021Q4	us-gaap	Interest Income Operating InterestIncomeOperating	1269	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	3310	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	2763	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	85285	usd
CY2021Q4	us-gaap	Interest Expense InterestExpense	118365	usd
	us-gaap	Interest Expense InterestExpense	111380	usd
	us-gaap	Interest Expense InterestExpense	230545	usd
CY2021Q4	bnet	Gain On Legal Dissolution Of Subsidiary GainOnLegalDissolutionOfSubsidiary	-10234501	usd
	bnet	Gain On Legal Dissolution Of Subsidiary GainOnLegalDissolutionOfSubsidiary	-10234501	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-83910	usd
CY2021Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10117405	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-108070	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10006719	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-729994	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	9444706	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1649421	usd
	us-gaap	Net Income Loss NetIncomeLoss	8780830	usd
CY2021Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-489	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-995	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-729994	usd
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9445195	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1649421	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8781825	usd
CY2022Q4	bnet	Net Income Loss Applicable To Bions Common Stockholders Per Basic And Diluted Common Share NetIncomeLossApplicableToBionsCommonStockholdersPerBasicAndDilutedCommonShare	-0.02
CY2021Q4	bnet	Net Income Loss Applicable To Bions Common Stockholders Per Basic And Diluted Common Share NetIncomeLossApplicableToBionsCommonStockholdersPerBasicAndDilutedCommonShare	0.23
	bnet	Net Income Loss Applicable To Bions Common Stockholders Per Basic And Diluted Common Share NetIncomeLossApplicableToBionsCommonStockholdersPerBasicAndDilutedCommonShare	-0.04
	bnet	Net Income Loss Applicable To Bions Common Stockholders Per Basic And Diluted Common Share NetIncomeLossApplicableToBionsCommonStockholdersPerBasicAndDilutedCommonShare	0.21
CY2022Q4	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	43620051	shares
CY2021Q4	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	41088992	shares
	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	43533789	shares
	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	40904342	shares
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11406339	usd
CY2021Q3	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	104500	usd
CY2021Q3	bnet	Commissions On Warrant Exercises CommissionsOnWarrantExercises	-1000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5126	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-663876	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11961589	usd
CY2021Q4	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	1632162	usd
CY2021Q4	bnet	Commissions On Warrant Exercises CommissionsOnWarrantExercises	-17601	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	12585	usd
CY2021Q4	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	8337	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	7500	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	9444706	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-873900	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-894579	usd
CY2022Q3	bnet	Sale Of Units Value SaleOfUnitsValue	320000	usd
CY2022Q3	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	56125	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	usd
CY2022Q3	bnet	Issuance Of Warrants For Services IssuanceOfWarrantsForServices	15000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	50000	usd
CY2022Q3	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	159433	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-919427	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1133448	usd
CY2022Q4	bnet	Sale Of Units Value SaleOfUnitsValue	226230	usd
CY2022Q4	bnet	Issuance Of Warrants For Services IssuanceOfWarrantsForServices	32250	usd
CY2022Q4	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	68088	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-729994	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	731961	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1536874	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1649421	usd
	us-gaap	Net Income Loss NetIncomeLoss	8780830	usd
	bnet	Gain On Legal Dissolutions Of Subsidiary GainOnLegalDissolutionsOfSubsidiary	10234501	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	724	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	580	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	43292	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	248409	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	223021	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	13125	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	127250	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-80062	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-77326	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-949097	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	130628	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	32308	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-49230	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	170000	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	179867	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1921861	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-852966	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	739486	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	92134	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-739486	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-92134	usd
	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits	546230	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	56125	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1736662	usd
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	18601	usd
	bnet	Redemption Of Preferred Series B Shares And Interest RedemptionOfPreferredSeriesBSharesAndInterest	-41000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	602355	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1677061	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2058992	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3160442	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4216321	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1101450	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4948282	usd
	bnet	Conversion Of Debt And Liabilities Into Common Units ConversionOfDebtAndLiabilitiesIntoCommonUnits	50000	usd
	bnet	Conversion Of Debt And Liabilities Into Common Units ConversionOfDebtAndLiabilitiesIntoCommonUnits	17711	usd
	bnet	Conversion Of Debt And Liabilities Into Notes Payable ConversionOfDebtAndLiabilitiesIntoNotesPayable	23943	usd
	bnet	Conversion Of Deferred Compensation To Notes Payable ConversionOfDeferredCompensationToNotesPayable	60000	usd
	bnet	Conversion Of Deferred Compensation To Notes Payable ConversionOfDeferredCompensationToNotesPayable	190000	usd
	bnet	Capitalized Interest In Property And Equipment CapitalizedInterestInPropertyAndEquipment	66104	usd
	bnet	Shares Issued For Warrant Exercise Commissions SharesIssuedForWarrantExerciseCommissions	50145	usd
	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable	135673	usd
	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable	54800	usd
	bnet	Cattle Per Head CattlePerHead	300	decimal
	bnet	Techwastage Techwastage	1500	decimal
	bnet	Percentage Of Sustainable PercentageOfSustainable	0.295	pure
	bnet	Description Of Kreider2 Poultry Project DescriptionOfKreider2PoultryProject	Bion has done extensive pre-development work related to a waste treatment/renewable energy production facility to treat the waste from KF’s approximately 6+ million chickens (planned to expand to approximately 9-10 million) (and potentially other poultry operations and/or other waste streams) ('Kreider Renewable Energy Facility' or ‘Kreider 2 Project’). On May 5, 2016, the Company executed a stand-alone joint venture agreement (“JVA”) with Kreider Farms covering all matters related to development and operation of Kreider 2 system to treat the waste streams from Kreider’s poultry facilities in Bion PA2 LLC (“PA2”). Now that development of the Company’s Gen3Tech is being deployed, the Company has commenced discussions with KF regarding updating and amending the JV agreement and anticipates executing an amended joint venture agreement during 2023. During May 2011 the PADEP certified a smaller version of the Kreider 2 Project (utilizing our 2nd generation technology) under the old EPA’s Chesapeake Bay model. The Company anticipates that if and when new designs are finalized utilizing our Gen3Tech, a larger Kreider 2 Project will be re-certified for a far larger number of credits (management’s current estimates are between 2-4 million (or more) nutrient reduction credits for treatment of the waste stream from Kreider’s poultry pursuant to the amended EPA Chesapeake Bay model and agreements between the EPA and PA).
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3451000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8291000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	10235000	usd
CY2022	bnet	Gain On Sale Of Domain Amount GainOnSaleOfDomainAmount	902490	usd
	bnet	Operating Loss OperatingLoss	1649000	usd
CY2022Q4	bnet	Working Capital WorkingCapital	58000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1574447	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1737000	usd
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5209000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	602000	usd
CY2018	bnet	Deferred Compensation Liability Amount Cancelled DeferredCompensationLiabilityAmountCancelled	2404000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zOB3DTxKXks5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_zYBFHUzNpcd4">Concentrations of credit risk</span>:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times may exceed federally insured limits. The Company has not experienced any losses on such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q4	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	44303654	shares
CY2021Q4	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	41475573	shares
	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	43758820	shares
	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	41315986	shares
CY2022Q4	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	704309	shares
CY2021Q4	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	704309	shares
	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	704309	shares
	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	704309	shares
CY2022Q4	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	43599345	shares
CY2021Q4	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	40771264	shares
	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	43054511	shares
	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	40611677	shares
CY2022Q4	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	20706	shares
CY2021Q4	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	317728	shares
	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	479278	shares
	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	292665	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43620051	shares
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41088992	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43533789	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40904342	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zSHQWx9BKd0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86D_zzIlqZONdYJl">Use of estimates</span>:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing the Company’s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
CY2022Q4	bnet	Computers And Office Equipment ComputersAndOfficeEquipment	15156	usd
CY2022Q2	bnet	Computers And Office Equipment ComputersAndOfficeEquipment	13598	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	3831927	usd
CY2022Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2892222	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3847083	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2905820	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10986	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10262	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	3836097	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2895558	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	98104	usd
	bnet	Non Cash Compensation NonCashCompensation	135648	usd
CY2022Q4	us-gaap	Depreciation Depreciation	394	usd
CY2021Q4	us-gaap	Depreciation Depreciation	332	usd
	us-gaap	Depreciation Depreciation	724	usd
	us-gaap	Depreciation Depreciation	580	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	714222	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	477374	usd
CY2022Q4	bnet	Interest Rate On Deferred Compensation InterestRateOnDeferredCompensation	0.04	pure
	bnet	Deferred Compensation Consecutive Trading Days DeferredCompensationConsecutiveTradingDays	P10D
CY2022Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	80000	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	0	usd
CY2021Q4	us-gaap	Assets Assets	297	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10154334	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9939148	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	214235	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	950	usd
CY2021Q4	us-gaap	Assets Assets	0	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10234501	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10009802	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	212263	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12436	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	10234501	usd
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9868495	usd
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.50
CY2022Q4	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	35416	usd
CY2021Q4	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	0	usd
	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	66104	usd
	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	0	usd
	bnet	Redemption Of Convertible Preferred Stock RedemptionOfConvertiblePreferredStock	41000	usd
	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	704309	shares
	bnet	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	74834	shares
	bnet	Common Stock Shares Issued Upon Exercise Of Warrants CommonStockSharesIssuedUponExerciseOfWarrants	74834	shares
	bnet	Warrants Exercised For Common Stock WarrantsExercisedForCommonStock	56125	usd
CY2022Q4	bnet	Sale Of Unit Price Per Unit SaleOfUnitPricePerUnit	1.00
CY2022Q4	us-gaap	Share Price SharePrice	0.75
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	546230	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	546230	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	20700000	shares
CY2022Q2	bnet	Sharebased Compensation Granted SharebasedCompensationGranted	720000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11201600	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.80
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M12D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4429263	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11201600	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.79
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M23D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5757755	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	0	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	0	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	0	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	0	usd
CY2022Q2	bnet	Compensation Increased CompensationIncreased	25000	usd
CY2021Q4	bnet	Exercise Bonus ExerciseBonus	0.75	pure
	bnet	Warrants Held By Trust Owned WarrantsHeldByTrustOwned	3000000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	17698381	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2665500	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	666375	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	666375	usd
CY2022Q3	bnet	Aggregate Payment AggregatePayment	1999125	usd
CY2022Q1	bnet	Sale Of Domain Description SaleOfDomainDescription	the Company entered into an agreement to sell domain name <biontech.com> and other related assets to BioNTech SE (“BNTX”) for the sum of $950,000 (before expenses related to the transaction) which sale was closed/completed on April 2, 2022 with a one-time gain of $902,490.
CY2021Q4	us-gaap	Long Term Construction Loan Current LongTermConstructionLoanCurrent	10010000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	2255802	usd
CY2021Q4	us-gaap	Assets Assets	297	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10154334	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9939148	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	214235	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	950	usd
CY2021Q4	us-gaap	Assets Assets	0	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10234501	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10009802	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	212263	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12436	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	10234501	usd
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9868495	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	75000	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	75000	usd
CY2022Q4	bnet	Undiscounted Cash Flow UndiscountedCashFlow	150000	usd
CY2022Q4	bnet	Less Imputed Interest LessImputedInterest	-14557	usd
CY2022Q4	us-gaap	Capital Leases Contingent Rental Payments Due CapitalLeasesContingentRentalPaymentsDue	135443	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y29D
CY2022Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.10	pure
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3470000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	50000	shares
CY2022Q4	bnet	Granted Options Exercisable GrantedOptionsExercisable	2.00

Files In Submission

Name	View Source	Status
0001079973-23-000168-index-headers.html	Edgar Link	pending
0001079973-23-000168-index.html	Edgar Link	pending
0001079973-23-000168.txt	Edgar Link	pending
0001079973-23-000168-xbrl.zip	Edgar Link	pending
bion_10q.htm	Edgar Link	pending
bnet-20221231.xsd	Edgar Link	pending
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32x1.htm	Edgar Link	pending
ex32x2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
bnet-20221231_cal.xml	Edgar Link	unprocessable
bnet-20221231_def.xml	Edgar Link	unprocessable
bnet-20221231_lab.xml	Edgar Link	unprocessable
bnet-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bion_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2023 Q1 Form 10-Q Financial Statement

#000107997323000168 Filed on February 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2023 Q1 Form 10-Q Financial Statement

#000107997323000168 Filed on February 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet